Dean Najarian

Title: Dean Najarian: Innovator in Extended Release Injectable Formulations

Introduction

Dean Najarian is a notable inventor based in Wrentham, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of dosing regimens for injectable formulations. His work focuses on improving treatment methods for patients requiring long-acting medications.

Latest Patents

Najarian holds a patent for "Dosing regimens associated with extended release paliperidone injectable formulations." This invention provides methods for treating patients with long-acting injectable paliperidone palmitate formulations. The patent outlines techniques for mitigating adverse changes in blood lipid levels in patients treated with paliperidone palmitate extended-release injectable suspension. This includes transitioning patients to a six-month dosing interval formulation, enhancing the overall treatment experience.

Career Highlights

Dean Najarian is associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work at Janssen has allowed him to focus on innovative solutions that address critical healthcare needs. His dedication to improving patient outcomes through research and development is commendable.

Collaborations

Throughout his career, Najarian has collaborated with esteemed colleagues such as Srihari Gopal and Ruth Milz. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Dean Najarian's contributions to the field of pharmaceuticals, particularly through his patent on extended release injectable formulations, highlight his commitment to advancing medical treatments. His work continues to impact patient care positively.